These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7594331)

  • 41. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW; Ballard ED; Koch FK; Gautille TC; Bagin RG
    J Clin Gastroenterol; 2009 Apr; 43(4):323-6. PubMed ID: 18758373
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early effects of intravenous administrations of lansoprazole and famotidine on intragastric pH.
    Iida H; Inamori M; Akimoto K; Mawatari H; Endo H; Nozaki Y; Akiyama T; Ikeda T; Sakamoto Y; Fujita K; Yoneda K; Takahashi H; Yoneda M; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
    Hepatogastroenterology; 2009; 56(90):551-4. PubMed ID: 19579641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous lansoprazole: in erosive oesophagitis.
    Dando TM; Plosker GL
    Drugs; 2004; 64(18):2085-9; discussion 2090. PubMed ID: 15341501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of lansoprazole on gastric ulcer healing and mucin content.
    Komuro Y; Ishii K; Miyake Y; Tanabe S; Oida M; Saigenji K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S47-51. PubMed ID: 7594339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
    Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg.
    Katz PO; Xue S; Castell DO
    Aliment Pharmacol Ther; 2001 May; 15(5):647-52. PubMed ID: 11328258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacodynamic modeling of lansoprazole using an indirect irreversible response model.
    Puchalski TA; Krzyzanski W; Blum RA; Jusko WJ
    J Clin Pharmacol; 2001 Mar; 41(3):251-8. PubMed ID: 11269565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous administration of lansoprazole: a preliminary study of dose ranging and efficacy in upper gastrointestinal bleeding.
    Aoki T
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():51-7. PubMed ID: 7495944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
    Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
    World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absence of nocturnal acid breakthrough in Helicobacter pylori-positive subjects treated with twice-daily omeprazole.
    Martínek J; Pantoflícková D; Hucl T; Benes M; Dorta G; Lukás M; Spicák J
    Eur J Gastroenterol Hepatol; 2004 May; 16(5):445-50. PubMed ID: 15097035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
    Bell NJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of frequent dosing of an oral proton pump inhibitor on intragastric pH.
    Pais SA; Nathwani RA; Dhar V; Nowain A; Laine L
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1607-13. PubMed ID: 16696810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Double-blind, randomized controlled study to assess the effects of lansoprazole 30 mg and lansoprazole 15 mg on 24-h oesophageal and intragastric pH in Chinese subjects with gastro-oesophageal reflux disease.
    Wong WM; Lai KC; Hui WM; Lam KF; Huang JQ; Hu WH; Wong NY; Lam CL; Xia HH; Chan AO; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2004 Feb; 19(4):455-62. PubMed ID: 14871286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
    Nishina K; Mikawa K; Maekawa N; Takao Y; Shiga M; Obara H
    Anesth Analg; 1996 Apr; 82(4):832-6. PubMed ID: 8615506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of oral doses of lansoprazole and omeprazole on gastric pH.
    Tolman KG; Sanders SW; Buchi KN; Karol MD; Jennings DE; Ringham GL
    J Clin Gastroenterol; 1997 Mar; 24(2):65-70. PubMed ID: 9077718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.